• LAST PRICE
    0.2400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.2400 / 0.2400
  • Day Range
    Low 0.2400
    High 0.2400
  • 52 Week Range
    Low 0.2039
    High 0.4463
  • Volume
    25,000

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.24
TimeVolumeEDTXF
09:32 ET250000.24
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEDTXF
Spectral Medical Inc
90.5M
-7.6x
---
United StatesODTC
Odonate Therapeutics Inc
52.7M
-0.7x
---
United StatesPMCB
PharmaCyte Biotech Inc
55.6M
-11.0x
---
United StatesGBLP
Global Pharmatech Inc
55.3M
-2.1x
---
United StatesEQ
Equillium Inc
39.8M
-0.5x
---
United StatesASPI
ASP Isotopes Inc
62.5M
0.0x
---
As of 2023-02-04

Company Information

Spectral Medical Inc. is a Canada-based company that develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company's EAA. It is engaged in the development of biochemical markers for the clinical syndrome known as septic shock. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development as well as in products manufactured by other diagnostic companies. The Company through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. Its dialysis machine, SAMI is targeting the acute RRT market, while its home hemodialysis machine, DIMI is targeting the chronic RRT market.

Contact Information

Headquarters
135 The West Mall, Unit 2TORONTO, ON, Canada M9C 1C2
Phone
416-626-3233
Fax
416-626-3233

Executives

Non-Executive Independent Chairman of the Board
Anthony Bihl
President, Director
Paul Walker
Chief Executive Officer
Chris Seto
Chief Financial Officer
Blair Mcinnis
Chief Medical Officer
John Kellum

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$68.0M
Revenue (TTM)
$1.2M
Shares Outstanding
278.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.70
EPS
$-0.03
Book Value
$0.01
P/E Ratio
-7.6x
Price/Sales (TTM)
54.8
Price/Cash Flow (TTM)
---
Operating Margin
-682.12%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.